Investigator Profiles
Our network includes experienced principal investigators with proven track records across therapeutic areas and trial phases.
Our Investigators
Principal investigators within the Clinitiative network are selected based on research experience, enrollment performance, and commitment to data quality.
Average Experience
Our investigators average over 15 years of clinical trial experience across Phase I–IV studies.
KOLScore™ Evaluated
Every investigator is assessed through our proprietary KOLScore™ framework measuring influence, output, and trial performance.
Therapeutic Diversity
Investigators collectively cover 18 therapeutic areas, ensuring protocol-specific expertise for sponsor alignment.
Featured Investigators
A selection of principal investigators representing the depth of expertise within our network.
Dr. Maria Gonzalez, MD
Houston Clinical Research Center — Houston, TX
Board-certified oncologist with 18 years of clinical research experience. 85 trials | 42 publications
Dr. James Whitfield, MD, PhD
Northeast Research Institute — Boston, MA
Neuroscientist specializing in Alzheimer's disease and movement disorders. 112 trials | 67 publications
Dr. Linda Chen, MD
Pacific Coast Clinical Trials — San Diego, CA
Dermatology researcher with extensive Phase II–IV trial leadership. 64 trials | 31 publications
Dr. Robert Adkins, MD
Southeastern Medical Research — Atlanta, GA
Infectious disease specialist with pivotal vaccine development contributions. 93 trials | 55 publications
Dr. Sarah Mendelson, MD
Great Lakes Research Partners — Chicago, IL
Endocrinologist focused on metabolic disease research. 78 trials | 38 publications
Dr. Thomas Reyes, MD
Mountain West Clinical Group — Denver, CO
GI researcher with deep experience in NASH, IBD, and hepatocellular carcinoma trials. 59 trials | 28 publications
Connect with Our Investigators
Interested in learning more about specific investigators or their therapeutic expertise?